SCHEMBL722977

SCHEMBL722977

COCC(N)C(O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 2/20 0.53
KDM4E B2RXH2 2/20 0.53
ADRA2A P08913 1/20 0.53
LMNA P02545 1/20 0.53
HIF1A Q16665 1/20 0.53
ALDH1A1 P00352 2/20 0.52
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
AOC3 Q16853 8/20 0.43
MAPT P10636 1/20 0.43
CHRM2 P08172 1/20 0.41
ADRA1A P35348 1/20 0.41
RGS12 O14924 1/20 0.41
GLA P06280 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2066405 1.00 ADRA2C (0.53) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL13971006 1.00 ADRA2C (0.53) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL4074447 1.00 ADRA2C (0.53) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL23980139 0.78 LMNA (0.50) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL2736639 0.78 LMNA (0.50) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL27257662 0.78 LMNA (0.50) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL12418041 0.78 KDM4E (0.59) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL5172179 0.78 KDM4E (0.59) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL837417 0.78 KDM4E (0.59) ADRA2CKDM4EADRA2ALMNAHIF1A
SCHEMBL4272229 0.78 KDM4E (0.59) ADRA2CKDM4EADRA2ALMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0433897-B1 Process for preparing an optically active cyclobutane nucleoside SQUIBB & SONS INC (US) 1997-10-01 EP claimed
US-5064961-A PROCESS FOR PREPARING AN OPTICALLY ACTIVE CYCLOBUTANE NUCLEOSIDE E. R. SQUIBB & SONS, INC. (US) 1991-11-12 US claimed
EP-0433897-A2 Process for preparing an optically active cyclobutane nucleoside E.R. SQUIBB & SONS, INC. (US) 1991-06-26 EP claimed
US-20240124408-A1 Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application SANOFI (FR) 2024-04-18 US disclosed
US-20120048295-A1 CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2012-03-01 US disclosed
WO-2010104816-A1 CLEANING FORMULATION FOR REMOVING RESIDUES ON SURFACES FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2010-09-16 WO disclosed
US-7306884-B2 Dye-containing curable composition, color filter prepared using the same, and process of preparing color filter FUJIFILM CORPORATION (JP) 2007-12-11 US disclosed
US-7306884-B2 Dye-containing curable composition, color filter prepared using the same, and process of preparing color filter FUJIFILM CORPORATION (JP) 2007-12-11 US disclosed
US-20070072096-A1 Negative curable dye-containing composition, color filter, and method of manufacturing the same FUJI PHOTO FILM CO., LTD. 2007-03-29 US disclosed
US-7078406-B2 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2006-07-18 US disclosed
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes Life Technologies Corporation 2004-12-09 US disclosed
US-5198583-A Optically active cyclobutane nucleoside and intermediates, therefor E. R. SQUIBB & SONS, INC. (US) 1993-03-30 US disclosed
US-5064961-A PROCESS FOR PREPARING AN OPTICALLY ACTIVE CYCLOBUTANE NUCLEOSIDE E. R. SQUIBB & SONS, INC. (US) 1991-11-12 US disclosed
EP-0433897-A2 Process for preparing an optically active cyclobutane nucleoside E.R. SQUIBB & SONS, INC. (US) 1991-06-26 EP disclosed
US-4256911-A TRIFLUOROMETHYL-CARBOXY ESTERS HOFFMANN-LA ROCHE INC. (US) 1981-03-17 US disclosed
US-4237276-A CARDIOVASCULAR AGENTS, INDUCTION OF LABOR, TERMINATION OF PREGNANCY HOFFMANN-LA ROCHE INC. (US) 1980-12-02 US disclosed
US-4211724-A ENANTIOMORPHS, INTERMEDIATE AMIDES WITH ASSYMETRIC CARBON ATOM HOFFMAN-LA ROCHE INC. (US) 1980-07-08 US disclosed
US-4190587-A PROSTAGLANDINS HOFFMANN-LA ROCHE INC. (US) 1980-02-26 US disclosed
US-4187381-A CARDIOVASCULAR AGENTS; OXYTOCICS HOFFMANN-LA ROCHE INC. (US) 1980-02-05 US disclosed
US-4112225-A 16-CF3 prostaglandins HOFFMAN-LA ROCHE INC. (US) 1978-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 ADRA2C 2623/4885KDM4E 1438/4885ADRA2A 2908/4885
US-20240124408-A1 Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application TRPM8, TAS2R8, TRPM7 ADRA2C 465/4885KDM4E 2867/4885ADRA2A 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.